Andrew Witty, UnitedHealth Group’s CEO, defended the company’s commitment to ... Analysts had expected quarterly earnings of $6.73 per share on $101.6 billion in earnings, according to FactSet. Though the flurry of social media criticism has moderated ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Andrew Witty, UnitedHealth Group’s CEO, defended the company ... $6.73 per share on $101.6 billion in earnings, according to FactSet. Though the flurry of social media criticism has moderated ...

It happened again on Thursday morning, when Cigna Group reported quarterly earnings. The results missed estimates and management’s financial guidance for next year was lower than Wall Street expected.

For two years in a row, shares of our healthcare juggernaut UnitedHealth Group have lagged significantly. So, why are we bullish UNH? Find out.

Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian Thompson, who headed the company's UnitedHealthcare unit. See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%.

Large-scale attacks on health providers expose the data of millions of Americans each year. Consumers must remain vigilant, experts say.

The number of people affected by a UnitedHealth data breach in February 2024 was actually higher than previously reported and was the largest medical data breach in U.S. history.

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other best beginner stocks to buy in 2025.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite surges for obesity drugmakers Eli Lilly and Novo Nordisk. But the sector is off to a healthy start in 2025.